These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31506805)

  • 1. Analysis of fistula formation of T4 esophageal cancer patients treated by chemoradiotherapy.
    Taniyama TK; Tsuda T; Miyakawa K; Arai H; Doi A; Hirakawa M; Horie Y; Mizukami T; Izawa N; Ogura T; Sunakawa Y; Nakajima TE
    Esophagus; 2020 Jan; 17(1):67-73. PubMed ID: 31506805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors and clinical courses of chemoradiation-related arterio-esophageal fistula in esophageal cancer patients with clinical invasion of the aorta.
    Taniguchi H; Yamazaki K; Boku N; Funakoshi T; Hamauchi S; Tsushima T; Todaka A; Sakamoto T; Tomita H; Machida N; Taku K; Fukutomi A; Onozawa Y; Tsubosa Y; Sato H; Nishimura T; Yasui H
    Int J Clin Oncol; 2011 Aug; 16(4):359-65. PubMed ID: 21347631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for esophageal fistula in thoracic esophageal squamous cell carcinoma invading adjacent organs treated with definitive chemoradiotherapy: a monocentric case-control study.
    Kawakami T; Tsushima T; Omae K; Ogawa H; Shirasu H; Kito Y; Yoshida Y; Hamauchi S; Todaka A; Machida N; Yokota T; Yamazaki K; Fukutomi A; Onozawa Y; Yasui H
    BMC Cancer; 2018 May; 18(1):573. PubMed ID: 29776344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esophageal fistula after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal squamous cell carcinoma.
    Pao TH; Chen YY; Chang WL; Chang JS; Chiang NJ; Lin CY; Lai WW; Tseng YL; Yen YT; Chung TJ; Lin FC
    PLoS One; 2021; 16(5):e0251811. PubMed ID: 33989365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective trial of concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil and cisplatin for T4 esophageal cancer with or without fistula.
    Nishimura Y; Suzuki M; Nakamatsu K; Kanamori S; Yagyu Y; Shigeoka H
    Int J Radiat Oncol Biol Phys; 2002 May; 53(1):134-9. PubMed ID: 12007951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors for Esophageal Fistula Associated With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Cancer: A Supplementary Analysis of JCOG0303.
    Tsushima T; Mizusawa J; Sudo K; Honma Y; Kato K; Igaki H; Tsubosa Y; Shinoda M; Nakamura K; Fukuda H; Kitagawa Y;
    Medicine (Baltimore); 2016 May; 95(20):e3699. PubMed ID: 27196482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esophageal bypass operation prior to definitive chemoradiotherapy in advanced esophageal cancer with tracheobronchial invasion.
    Hihara J; Hamai Y; Emi M; Aoki Y; Taomoto J; Miyata Y; Okada M
    Ann Thorac Surg; 2014 Jan; 97(1):290-5. PubMed ID: 24200399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative CT analysis to predict esophageal fistula in patients with advanced esophageal cancer treated by chemotherapy or chemoradiotherapy.
    Shi YJ; Liu C; Wei YY; Li XT; Shen L; Lu ZH; Sun YS
    Cancer Imaging; 2022 Nov; 22(1):62. PubMed ID: 36333763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a risk prediction model for radiotherapy-related esophageal fistula in esophageal cancer.
    Xu Y; Wang L; He B; Li W; Wen Q; Wang S; Sun X; Meng X; Yu J
    Radiat Oncol; 2019 Oct; 14(1):181. PubMed ID: 31640802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced esophageal cancer with an esophago-bronchial fistula successfully treated by chemoradiotherapy following esophageal bypass surgery: report of a case.
    Aoki Y; Hihara J; Sakogawa K; Taomoto J; Hamai Y; Emi M; Okada M
    Surg Today; 2012 Nov; 42(11):1088-90. PubMed ID: 22955635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High incidence of esophageal fistula on patients with clinical T4b esophageal squamous cell carcinoma who received chemoradiotherapy: A retrospective analysis.
    Chen B; Deng M; Yang C; Dragomir MP; Zhao L; Bai K; Xi M; Hu Y; Zhu Y; Li Q
    Radiother Oncol; 2021 May; 158():191-199. PubMed ID: 33667583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral air embolism caused by chemoradiotherapy for esophageal cancer.
    Miyamoto S; Mashimo Y; Horimatsu T; Ezoe Y; Morita S; Muto M; Chiba T
    J Clin Oncol; 2012 Sep; 30(25):e237-8. PubMed ID: 22826283
    [No Abstract]   [Full Text] [Related]  

  • 13. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Outcome of Definitive Chemoradiotherapy and Induction Chemoradiotherapy Followed by Surgery for T4 Esophageal Cancer with Tracheobronchial Invasion.
    Yamaguchi S; Morita M; Yamamoto M; Egashira A; Kawano H; Kinjo N; Tsujita E; Minami K; Ikebe M; Ikeda Y; Kunitake N; Toh Y
    Ann Surg Oncol; 2018 Oct; 25(11):3280-3287. PubMed ID: 30051363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoradiotherapy for T4 and/or M1 lymph node esophageal cancer: experience since 2000 at a high-volume center in Japan.
    Jingu K; Umezawa R; Matsushita H; Sugawara T; Kubozono M; Yamamoto T; Ishikawa Y; Kozumi M; Takahashi N; Katagiri Y; Kadoya N; Takeda K
    Int J Clin Oncol; 2016 Apr; 21(2):276-282. PubMed ID: 26324841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Outcome After Esophagectomy or Definitive Chemoradiotherapy in Elderly Patients (≥80 Years) With Esophageal Cancer.
    Shimonosono M; Sasaki K; Tsuruda Y; Noda M; Uchikado Y; Arigami T; Matsushita D; Mori S; Kurahara H; Nakajo A; Ohtsuka T
    Anticancer Res; 2022 Aug; 42(8):3953-3961. PubMed ID: 35896243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of hemoglobin level on survival in definitive chemoradiotherapy for T4/M1 lymph node esophageal cancer.
    Zenda S; Hironaka S; Boku N; Yamazaki K; Yasui H; Fukutomi A; Yoshino T; Onozawa Y; Nishimura T
    Dis Esophagus; 2008; 21(3):195-200. PubMed ID: 18430098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definitive chemoradiotherapy plus cetuximab for cancer in the oesophagus or gastro-oesophageal junction.
    von Döbeln GA; Wagenius G; Holtved E; Jacobsen AB; Nilsson M; Yu J; Baeksgaard L
    Cancer Treat Res Commun; 2020; 24():100187. PubMed ID: 32619832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of esophagorespiratory fistulae in patients with esophageal squamous cell carcinoma (SCCA).
    Choi MK; Park YH; Hong JY; Park HC; Ahn YC; Kim K; Shim YM; Kang WK; Park K; Im YH
    Med Oncol; 2010 Dec; 27(4):1234-8. PubMed ID: 19924573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factors for the Development of Esophagorespiratory Fistula in Esophageal Cancer.
    Paul G; Bohle W; Zoller W
    J Gastrointestin Liver Dis; 2019 Sep; 28(3):265-270. PubMed ID: 31517322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.